These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
7. Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018). Pfaller MA; Carvalhaes C; Messer SA; Rhomberg PR; Castanheira M Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015043 [TBL] [Abstract][Full Text] [Related]
8. Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method. Arendrup MC; Meletiadis J; Zaragoza O; Jørgensen KM; Marcos-Zambrano LJ; Kanioura L; Cuenca-Estrella M; Mouton JW; Guinea J Clin Microbiol Infect; 2018 Nov; 24(11):1200-1204. PubMed ID: 29505881 [TBL] [Abstract][Full Text] [Related]
9. Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species. Locke JB; Almaguer AL; Zuill DE; Bartizal K Antimicrob Agents Chemother; 2016 Oct; 60(10):6100-7. PubMed ID: 27480852 [TBL] [Abstract][Full Text] [Related]
10. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. Pfaller MA; Castanheira M; Diekema DJ; Messer SA; Moet GJ; Jones RN J Clin Microbiol; 2010 May; 48(5):1592-9. PubMed ID: 20335424 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ibrexafungerp against Candida species isolated from blood cultures. Determination of wild-type populations using the EUCAST method. Mesquida A; Díaz-García J; Sánchez-Carrillo C; Muñoz P; Escribano P; Guinea J Clin Microbiol Infect; 2022 Jan; 28(1):140.e1-140.e4. PubMed ID: 34619396 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods. Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E; Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae. Tóth Z; Forgács L; Locke JB; Kardos G; Nagy F; Kovács R; Szekely A; Borman AM; Majoros L J Antimicrob Chemother; 2019 Dec; 74(12):3505-3510. PubMed ID: 31539426 [TBL] [Abstract][Full Text] [Related]
15. Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Espinel-Ingroff A; Arendrup MC; Pfaller MA; Bonfietti LX; Bustamante B; Canton E; Chryssanthou E; Cuenca-Estrella M; Dannaoui E; Fothergill A; Fuller J; Gaustad P; Gonzalez GM; Guarro J; Lass-Flörl C; Lockhart SR; Meis JF; Moore CB; Ostrosky-Zeichner L; Pelaez T; Pukinskas SR; St-Germain G; Szeszs MW; Turnidge J Antimicrob Agents Chemother; 2013 Dec; 57(12):5836-42. PubMed ID: 24018263 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin. García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020). Carvalhaes CG; Klauer AL; Rhomberg PR; Pfaller MA; Castanheira M J Clin Microbiol; 2022 Apr; 60(4):e0244921. PubMed ID: 35249367 [TBL] [Abstract][Full Text] [Related]
18. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates. Eschenauer GA; Nguyen MH; Shoham S; Vazquez JA; Morris AJ; Pasculle WA; Kubin CJ; Klinker KP; Carver PL; Hanson KE; Chen S; Lam SW; Potoski BA; Clarke LG; Shields RK; Clancy CJ Antimicrob Agents Chemother; 2014; 58(4):1897-906. PubMed ID: 24395235 [TBL] [Abstract][Full Text] [Related]
19. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Jones RN; Turnidge J; Diekema DJ J Clin Microbiol; 2010 Jan; 48(1):52-6. PubMed ID: 19923478 [TBL] [Abstract][Full Text] [Related]
20. Resistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture Samples. Bordallo-Cardona MÁ; Marcos-Zambrano LJ; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29712651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]